Product Information
DORZOLAMIDE-TIMOLOL EYE DROPS is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.8927 per ML under NDC 71921022610. Its NADAC has been published 154 times since Oct 25, 2023.
FDA first approved this application on Sep 3, 2014. Its Orange Book therapeutic-equivalence code is AT1.
Strength
20; 5 mg/mL; mg/mL
Manufacturer
Florida Pharmaceutical Products, LLCNDC
71921022610
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA202054FDA Approved
9/3/2014
TE Code
AT1
On Market Since
8/16/2023
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has been published 154 times since Oct 25, 2023, and over the history we have for it it has declined 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8927 per ML |
|---|---|
| All-time high | $1.1820 (Apr 16, 2025) |
| All-time low | $0.8853 (Jul 22, 2026) |
| 52-week high | $1.0228 |
| 52-week low | $0.8853 |
| Median price | $1.0419 |
| Average price | $1.0271 |
| Largest weekly change | +16.8% (Jun 19, 2024) |
| Weeks tracked | 154 |
| Tracking since | Oct 25, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dorzolamide hydrochloride timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Florida Pharmaceutical Products, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dorzolamide hydrochloride timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DORZOLAMIDE-TIMOLOL EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL EYE DROPS, manufactured by Florida Pharmaceutical Products, LLC, is $0.8927 per ML (NDC 71921022610), effective Sep 30, 2026.
How has the price of DORZOLAMIDE-TIMOLOL EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has declined 18.9%. It has been tracked across 154 weekly CMS publications since Oct 25, 2023.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL EYE DROPS?
Since Oct 25, 2023, the NADAC for DORZOLAMIDE-TIMOLOL EYE DROPS has ranged from a low of $0.8853 (Jul 22, 2026) to a high of $1.1820 (Apr 16, 2025), with a median of $1.0419 per ML.
Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of DORZOLAMIDE-TIMOLOL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE-TIMOLOL EYE DROPS?
DORZOLAMIDE-TIMOLOL EYE DROPS (NDC 71921022610) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.